¿Qué es el sitio web?

Oncoliq

🧬 We are developing screening methods for early cancer detection based on liquid biopsy using a small blood sample.

11/02/2026

We imagine a future where science is built through diverse perspectives, better questions, and research that truly reflects the world we live in.

On this International Day of Women and Girls in Science, we reaffirm our commitment to that future. One shaped by more women, stronger science, and earlier detection.

06/02/2026

The probability of developing invasive cancer over a lifetime is 1 in 3. However, the outcome of that story is within our control.

We used to live in a world of reactive detection, waiting for the body to "announce" a problem through symptoms. By then, the disease has often advanced, leading to aggressive treatments and lower survival rates.

Today, we are entering the era of proactive detection. By listening to molecular signals like miRNAs, we can identify cancer at its very origin. Detecting cancer early changes the human experience of the disease, making a 90% survival rate a reachable reality.

The path of knowledge is the path to survival.

20/11/2025

Today, we reflect on the importance of listening to what the body can’t yet say.

This World Pancreatic Cancer Day 🌍 we reaffirm our mission to make early detection accessible to everyone.

Dirección

Buenos Aires
1000-1499

Página web

https://www.linkedin.com/company/oncoliq/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Oncoliq publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.